Cardionet (BEAT)
Recs
spreadsheetV1
(< 20)
Submitted: 11/23/2009 1:27:23 AM :
Start Price:
$5.12
BEAT Score:
-3.72
This met a high level screen to indicate a buy and strong outperform against its peers (other tickers in its industry). My 1st version of this spreadsheet devles deep into the company's balnace sheet and recent income statements, combined with other relevant price data for the company including insider/institutional holdings, short interest, debt levels, etc.
Testing capabilities of this 1st version of my automated, valuation spreadhseet matched with my personal criteria and see how it holds up.
Recs
berrygeorge
(60.00)
Submitted: 11/12/2009 12:46:26 PM :
Start Price:
$4.97
BEAT Score:
+1.96
This company is unable to collect their bills and has recently rebilled all their customers. Look at their web site. This is a relatively new company with a good concept but no one wants to pay for it.
No end in sight. Will drop before it goes up.
Recs
Clint35
(68.50)
Submitted: 11/7/2009 1:33:42 AM :
Start Price:
$5.26
BEAT Score:
-8.88
It's close to it's 52 week low. Good time to buy. And it's in the healthcare sector. Low P/E.
Recs
Recs
UltraContrarian
(99.79)
Submitted: 10/25/2009 11:20:47 PM :
Start Price:
$6.38
BEAT Score:
-44.15
They still have a lot of work to do in order to improve their profitability. But they have the other 2 main characteristics I look for - a healthy balance sheet and expanding revenue.
Recs
sudspark
(< 20)
Submitted: 10/22/2009 4:15:16 PM :
Start Price:
$7.07
BEAT Score:
-31.39
Beaten down, will rebound 15-20%
Recs
bg11235
(89.95)
Submitted: 10/21/2009 1:19:06 PM :
Start Price:
$6.97
BEAT Score:
-30.26
Has found support and is now at a reasonable price.
Recs
CharlieBombay
(29.51)
Submitted: 10/9/2009 1:15:39 PM :
Start Price:
$7.13
BEAT Score:
-34.56
Teen Beat is a great magazine. They guys should do well for as long as there are teenagers.
Recs
Mrpresident77
(63.89)
Submitted: 9/25/2009 2:42:22 PM :
Start Price:
$6.95
BEAT Score:
-34.99
Making ALL SORTS of money i am not going to avoid this one. I just bought some. And my current rating is better than over 90% of the fool universe i believe is how that is calculated.
Recs
ttboydxb
(98.90)
Submitted: 9/18/2009 7:28:38 AM :
Start Price:
$7.45
BEAT Score:
-37.37
Nathan @ betapeg has a good write up on them, and the numbers look good!
Recs
BetapegLLC
(92.20)
Submitted: 9/17/2009 2:37:29 PM :
Start Price:
$7.63
BEAT Score:
-42.72
CardioNet (BEAT) is a newly public company having successfully raised $83 million in March 2008 and $152 million in July 2008. The Company has since made its first full year profit of $9 million. Revenues have increased 442% in the last 5 years and 65% in just the last year. The Company exhibits extremely high growth potential in a healthcare sector expected to grow substantially in the next decade. The stock is indicated by several factors to be one of the most undervalued companies on the NASDAQ. The stock price is only 11% more than book value and investors pay only $1.25 for every dollar of sales. Estimated earnings growth is also undervalued as indicated by a PEG ratio of 0.38. CardioNet has outperformed 8% of the market in the last 8 months. This indicates the stock to be highly undervalued relative to its fundamentals grade of 53%. CardioNet is valued at $32.91 for FY2009. With a current price of $7.28, BEAT is 352.11% undervalued for the fiscal year. Insiders have purchased and granted a substantial amount of shares indicating executives see great potential in the stock. The Company has an excellent balance sheet with many times more cash than short-term debts in addition to having no long-term debt. CardioNet pays no dividend. Earnings yield, return on equity, and profit margin are below the sector average. Risks include a history of net losses, dependence on physicians’ prescriptions, reimbursement failures, competition, macroeconomic difficulties, dependence on a limited number of suppliers, medical/product liability, patent infringement, government regulations, FDA approval, management integration, etc.
http://www.betapeg.com/stock_picks__reports
Recs
MrHappyFinance
(< 20)
Submitted: 9/17/2009 1:20:03 AM :
Start Price:
$7.63
BEAT Score:
-39.42
The healthcare industry is ripe for a major technology revolution. Small & mid-cap companies that provide valuable services such as BEAT will stand to benefit for many years to come. Whether they stay independant or get aquired by one of the major healthcare providers, BEAT will make investors happy in the long run.
Recs
dusand
(94.93)
Submitted: 9/11/2009 4:09:03 AM :
Start Price:
$7.15
BEAT Score:
-39.38
1. I like the idea of continuous real-time outpatient monitoring. 2. Strong balance sheet, no debt, good P/B ratio. 3. All-star players picked almost 40% of total outperform picks, but only about 10% of underperform ones.
Recs
louislombardi
(< 20)
Submitted: 8/26/2009 1:29:55 PM :
Start Price:
$7.74
BEAT Score:
-44.64
big call volume
Recs
thiscoloradokid
(< 20)
Submitted: 8/26/2009 12:37:34 PM :
Start Price:
$7.44
BEAT Score:
-42.35
Oversold and recent increase in range and volume.
Recs
Boum
(34.62)
Submitted: 8/22/2009 10:07:24 AM :
Start Price:
$14.82
BEAT Score:
-91.51
I do a mistake !
I didn't think this stock will perform before long, Looks LIFE.SW, who stay 5 years down after his tumble.
But I hope he will reach 10$ before fluctuate.
Recs
Lawrence56
(< 20)
Submitted: 7/26/2009 11:52:31 AM :
Start Price:
$6.20
BEAT Score:
-34.34
Medicare decision is under appeal
Recs
jts001
(< 20)
Submitted: 7/15/2009 7:39:08 PM :
Start Price:
$6.68
BEAT Score:
-46.08
Overly beaten down stock with no debt and cash in hand.
Recs
clarkinbrazil
(74.84)
Submitted: 7/13/2009 10:13:03 AM :
Start Price:
$6.12
BEAT Score:
-45.05
Numbers look very good, don't understand the sudden drop!
Recs
TCSekhar
(< 20)
Submitted: 7/11/2009 12:38:57 PM :
Start Price:
$5.81
BEAT Score:
-41.36
One-year Price chart with 50-day moving average: 16.29
----------------------------------------------------- -----------
*** NEGATIVE ****
O.K. to buy if stock price is above its 50-day moving average.
THERE ARE 7+ MILLION SHARES SHORT WHICH IS OVER 29% OF TOTAL OUTSTANDING SHARES. THESE SHORTS HAVE TO COVER BY PURCHASING ACTUAL SHARES FROM INSTITUTIONS/INSIDERS/US - AT SOME POINT OF TIME. THIS IS ABSOLUTELY ABNORMAL.
"HENCE THIS NEGATIVE MAY NOT COUNT FOR THIS STOCK"
P/S Ratio: 1.60
--------------------------------
*** POSITIVE ****
O.K. to buy if P/S is less than 10. P/S ratios between 3 and 5 are best for growth stocks. Ratios below 2 reflect value priced stocks.
Cash flow ratio: +11.6
--------------------------------
*** POSITIVE ****
O.K. to buy if Cash Flow per share is a positive number.
Avg Daily Volume: 1.6 Mil
--------------------------------
*** POSITIVE ****
O.K. to buy if Average Daily Volume is 100,000 shares or higher (0.1 mil), and above one million shares is best.
Financial Health Grade: C
--------------------------------
*** POSITIVE ****
O.K. to buy if Financial Health Grade = A, B or C
Growth Grade: C
--------------------------------
*** NEGATIVE ****
O.K. to buy if Growth Grade = “A” or “B”
POTENTIALLY THERE IS SLEEP DISORDER PRODUCT SOMNET COULD BE ANOTHER BREAKTHROUGH FOR ITS GROWTH IN FUTURE. BUT THIS IS UNKNOWN FACTOR YET.
Institutional Ownership: 79%
--------------------------------
*** POSITIVE ****
O.K. to buy if institutions own at least 30% of shares outstanding.
Number of Analysts making Buy/Sell/Hold Recommendations: Yahoo - 8, E*Trade - 13
----------------------------------------------------- -------------------------------------------
*** POSITIVE ****
O.K. to buy if a total of at least four analysts are listed as currently making strong buy, buy, hold, underperform, or sell recommendations. Look only at the total number of analysts making recommendations, not whether there are more buys than holds, etc.
===================================================
Two years ago in Mar 07, they acquired "PDS Heart" for less than $10 Million, and this year in Apr 09, they have acquired "BioTel Inc" for $13 Million paying CASH in full. So most probably their cash and equivalents on hand as of today could be anywhere near to $37 Million.
I believe that few of the institutions who are heavily invested with BEAT weren't too happy with the $4.82 per share deal when the market rate for (BTEL.OB) was below $2. And hence the sell off started. And when Randy figured that the Q2 results weren't going to meet the expectations, and there was already good sell off happening, he started to buy shares to show some internal transactions - to push the share value up. This didn't help that much. Now the shorts were waiting for a chance to nail this stock to ground, and Randy decided to minimize the negative impact of the Q2 results, on July 1st announced the new guidance with the worst possible scenario. This kicked off the sell off which made the stock fall from 14 to 9.
Since March, the shorts (hedges) were playing a major role in bringing this down investing over 90 million dollars assuming there will be huge sell off. Which left them with 5 million short shares until mid of June. I don't have the exact numbers now - but could be close to 6 to 8 million short as of today. Remember this stock was 98% institution and insider owned. Unless other institutions pull out their money, this stock will regain to its original value for sure very easily. The shorts are taking a huge risk.
Talking about future, Obama is towards cost reduction - but, he is also very much into technology. And when it comes to heart related wireless technology and equipments, Cardio has a huge potential with the benefits that they could currently provide with their product and software - which would be very useful for research. Added to that is the sleep disorder product which would hit the market. The increase of sales force is going to drive their business only higher. If Medicaid wouldn't pay for their product, there are thousands of others who currently can afford the extra money to go wireless for their heart treatment - which gives them greater flexibility and added advantages.
And, for now, once the financials come out for Q2 2009 (most probably before July 24th), its going to beat the guidance estimates and will raise. The lows today at 8.3 (shorts may take down further up-to 5 who knows within the next 10 days) will become history.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 29 1 2 Next »